TSX Delisting Review - Allon Therapeutics Inc. (Symbol: NPC)

TORONTO, May 30, 2013 /CNW/ - DELISTING REVIEW  Allon Therapeutics Inc. (the "Company") - Further to TSX Bulletin 2013-0099 dated February 5, 2013, TSX has determined to delist the common shares (Symbol: NPC) of the Company at the close of market on June 28, 2013 for failure to meet the continued listing requirements of TSX.  In addition, the common shares are suspended from trading immediately.

About TMX Group (TSX-X)
TMX Group's key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, TMX Select, Alpha Group, The Canadian Depository for Securities, Montreal Exchange, Canadian Derivatives Clearing Corporation, Natural Gas Exchange, BOX Options Exchange, Shorcan, Shorcan Energy Brokers, Equicom and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, data products and other services to the global financial community.  TMX Group is headquartered in Toronto and operates offices across Canada (Montreal, Calgary and Vancouver), in key U.S. markets (New York, Houston, Boston and Chicago) as well as in London, Beijing and Sydney.  For more information about TMX Group, visit our website at www.tmx.com.  Follow TMX Group on Twitter at http://twitter.com/tmxgroup.

SOURCE: TMX GROUP INC.